Showing results (121-130 of 339) with videos related to
Sort By:
Pageof 34
The EMBO Journal|May 1, 1990
Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant formJ V Gannon, R Greaves, R Iggo, et al.The EMBO Journal|December 1, 1992
Isolation and analysis of the fission yeast gene encoding polymerase delta accessory protein PCNAN H Waseem, K Labib, P Nurse, et al.Oncogene|September 1, 1994
Immunochemical analysis of the interaction of p53 with MDM2;--fine mapping of the MDM2 binding site on p53 using synthetic peptidesS M Picksley, B Vojtesek, A Sparks, et al.Cancer Surveys|January 1, 1993
The role of TP53 in breast cancer developmentR A Eeles, J Bartkova, D P Lane, et al.Oncogene|March 3, 1998
Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor moleculeR Fåhraeus, S Laín, K L Ball, et al.Journal of Immunological Methods|July 6, 1992
An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53B Vojtĕsek, J Bártek, C A Midgley, et al.Cell Death and Differentiation|March 6, 2010
Combination of nutlin-3 and VX-680 selectively targets p53 mutant cells with reversible effects on cells expressing wild-type p53C F Cheok, N Kua, P Kaldis, et al.Nucleic Acids Research|August 15, 1998
PCNA binding proteins in Drosophila melanogaster : the analysis of a conserved PCNA binding domainE Warbrick, W Heatherington, D P Lane, et al.Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|October 4, 2000
The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neckK Nylander, E Dabelsteen, P A HallThe Journal of Pathology|July 17, 1998
Why is p53 protein stabilized in neoplasia? Some answers but many more questions?V Save, K Nylander, P A HallPageof 34